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Multiple System Atrophy (MSA) is a sporadic, neurodegenerative disease that
consists of three conditions: autonomic dysfunction, Parkinsonism and cerebellar ataxia.
Our lab conducted an Affymetrix global gene expression analysis using pons tissue of
MSA patients to determine genes that are differentially expressed when compared to nonMSA controls. This study identified upregulated genes, including the C-X-C chemokine
receptor type 4, CXCR4, to which stromal cell-derived factor-I (SDF-1) is the natural
ligand. The CXCR4/SDF-1 signaling pair has been sho.wn to play multiple roles in the
brain, such as inducing neuronal apoptosis and promoting leukocyte recruitment during
inflammation. The MSA cerebellum presents a significant decrease in Purkinje cells,
which are responsible for coordinating motor movement; MSA patients suffer from
cerebellar ataxia. The study described in this thesis is the first to quantitatively
demonstrate that both CXCR4 and SDF-1 protein levels are significantly upregulated in
MSA Purkinje cells compared to controls. Furthermore, the apoptotic protease Caspase 3
is also expressed at a significantly higher level in Purkinje cells of MSA patients
compared to controls. These findings suggest that CXCR4/SDF-1 are associated with
neuronal apoptosis. Intervention of this pair's signaling cascade has the potential as being
a therapeutic target in MSA and other diseases affected by neuronal loss.
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INTRODUCTION
Multiple System Atrophy
Multiple System Atrophy (MSA) is a sporadic neurodegenerative disease that is
characterized by a combination of autonomic dysfunction, parkinsonism, and cerebellar
ataxia (Kaufmann et al., 2003; Wenning et al., 2004). Other characteristics seen in MSA
include dysautonomia, erectile dysfunction, urinary incontinence, and constipation
(Wenning et al., 2004; Wenning et al., 1994). This disease pathologically presents gliosis,
cellular death, and the presence of protein aggregates termed glial cytoplasmic inclusions
(Wenning et al., 2004). Interestingly, cognitive impairment is not seen in MSA patients
(Kaufmann et al., 2003; Wenning et al., 2004). MSA affects both men and women and
has an average age onset in the 50's (Kaufmann et al., 2003; Stefanova et al., 2005;
Schrag et al., 1999). There is rapid progression of the disease with a mean survival rate of
9 years (Kaufmann et al., 2003; Stefanova et al., 2005; Schrag et al., 1999). Postmortem
pathological confirmation is necessary for a definite diagnosis of MSA (Kaufmann et al.,
2003; Lin et al., 2004; Pountney et al., 2004). During the early stages of MSA, it is
difficult to differentiate from other neurodegenerative diseases such as Parkinson's
disease (PD) which can lead to a misdiagnosis (Kaufmann et al., 2003; Stefanova et al.,
2005; Schrag et al., 1999). The prevalence ofMSA is estimated to be 2-15 per 100,000,
although recently it has been suggested that this number is actually higher, but is reported
this way because of the previously mentioned difficulty of distinguishing MSA from
other disorders (Kaufmann et al., 2003; Stefanova et al., 2005; Schrag et al., 1999).
Studies have investigated MSA for genetic alterations that are responsible for autosomal
dominant ataxias (SCA-1 and SCA-3), but no changes in these genes were found
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(Castellani 1998). From what is known, MSA is a sporadic disease and studies strongly
suggest that MSA is acquired in a way that is separate from other central nervous system
diseases that have a known genetic cause (Castellani 1998). Currently, MSA is a terminal
disease without a cure.
There are two major forms ofMSA: striato-nigral MSA (MSA-SND) and
olivopontocerebellar MSA (MSA-OPCA), with autonomic dysfunction occuring in both
types (Wenning et al., 2004; Ozawa et al., 2004; Stefanova et al., 2005; Wenning et al.,
1997; Kaufmann et al., 2003). In MSA-SND, degeneration occurs primarily in the
striatum and substantia nigra, while the brainstem and cerebellum also undergo
degeneration in MSA-OPCA (Wenning et al., 2004; Ozawa et al., 2004; Stefanova et al.,
2005; Wenning et al., 1997). There is much overlap between the two types and all MSA
patients display degeneration in the pons (Wenning et al., 2004; Ozawa et al., 2004;
Stefanova et al., 2005; Wenning et al., 1997). Generally, MSA-SND patients are
characterized as having Parkinson-like symptoms, while patients with MSA-OPCA
typically present a more advanced cerebellar ataxia (Wenning et al., 2004; Ozawa et al.,
2004; Stefanova et al., 2005; Wenning et al., 1997).
Cerebellum Anatomy and Background
MSA-OPCA is the form of interest for the current study in which degeneration is
present in the brainstem and cerebellum. The cerebellum is located below the cerebrum
and just above the brain stem. Throughout the years, the cerebellum has always been
categorized as its own distinct subdivision of the brain (Glickstein et al., 2009).
Anatomically, the cerebellum is a structure that is highly foliated and is connected to the
rest of the brain by three column-like structures called cerebellar peduncles (Glickstein et
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al., 2008). When looking at the human brain from a superior view, the cerebellum is not
visible because it is covered by the occipital lobe of the cerebral cortex (Glickstein et al.,
2009). The cerebellum is well known for its involvement in reflex adaptation and most
notably for its role in the process of fine and sequential motor movements (Glickstein et
al., 2009). Since this current study focuses specifically on MSA-OPCA, and therefore,
cerebellar ataxia, the cerebellum's function of controlling motor movements is of
particular interest.
Despite its physiological complexity, the cerebellum is composed of only 3
layers: granule cell (GC) layer, Purkinje cell (PC) layer, and molecular layer (Sillitoe et
al., 2007). Directly above the white matter core of the cerebellum is the granule cell layer
and it is composed mostly of small granule cells which are the most abundant neuronal
type in the brain (Sillitoe et al., 2007). The GC layer also contains other cell types such as
Golgi cells, Lugaro cell intemeurons, and unipolar Brush cells (Mugnaini et al., 1997).
The neighboring layer is the Purkinje cell layer and it is composed of large Purkinje cell
bodies and smaller Bergmann glia cells (Voogd & Glickstein 1998). The final and most
superficial layer is the molecular layer which contains components such as GC axons, PC
dendrites, Bergmann glia fibers, and basket and stellate cell intemeurons (Voogd &
Glickstein 1998).
There are two types of afferent structures involved in the circuitry of the
cerebellum, which are called mossy fibers and climbing fibers (Sillitoe et al., 2007).
Mossy fibers are specialized projections that supply the cerebellum with input from
numerous regions of the brain and spinal cord (Sillitoe et al., 2007). Climbing fibers are
also specialized projections that provide the cerebellum with input, but only from a single
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area of the brain stem called the inferior olive (Sillitoe et al., 2007). Each climbing fiber
in the cerebellum interacts with the dendrites of one Purkinje cell (Sillitoe et al., 2007).
Mossy fibers have their termination point in the GC layer, while climbing fibers have
their termination in the molecular layer (Sillitoe et al., 2007). Ultimately, information
flows into the cerebellum when mossy fibers synapse on granule cells, and climbing
fibers synapse on Purkinje cells (Sillitoe et al., 2007). Interestingly, all afferent pathways
into the cerebellum ultimately signal the Purkinje cells (Purves et al., 2001 ). Parallel
fibers, which are the axons of granule cells, synapse on a specialized area of the Purkinje
cell dendritic tree (Purves et al., 2001). The parallel fibers and climbing fibers both excite
Purkinje cells (Purves et al., 2001 ).

Purkinje Cells of the Cerebellum
Purkinje cells of the cerebellum are found in the Purkinje cell layer, and have a
noticeably large soma (Sillitoe et al., 2007). Purkinje cells are inhibitory cells, and they
are of great importance because their axons provide the only output from the cerebellar
cortex (Glickstein et al., 2009). Thus, Purkinje cells are a necessary component of the
motor system of the human body that is responsible for muscle tone and movement
(Herndon 1963). Each Purkinje cell receives its input from the inferior olive via climbing
fibers that synapse on the Purkinje cell dendrites and from other brain areas through
parallel fibers that also innervate Purkinje cells (Purves et al., 2001 ). Purkinje cells have
gained much attention for their degeneration in many conditions such as ischemia,
mitochondrial disorders, Alzheimer's disease, Huntington's disease, autism, and
alcoholism (Sama & Hawkes 2003). Studies have confirmed that there is an evident loss
of Purkinje cells in MSA (Spokes et al., 1979; Kume et al., 1991; Wenning et al., 1996).
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Purkinje cell degeneration phenotypically presents as ataxia and tremor (Sama &
Hawkes 2003), which is the common symptom observed in MSA-OPCA (Wenning et al.,
2004; Ozawa et al., 2004; Stefanova et al., 2005; Wenning et al., 1997). Although
Purkinje cell degeneration is present in normal aging to a certain degree, a pronounced
loss of Purkinje cells is not normal (Sama & Hawkes 2003). It is thought that in the adult
human, oxidative stress plays a role in the normal Purkinje cell death that accompanies
aging (Bickford et al., 2000), yet the cause of death of Purkinje cells in MSA in
unknown. It is important to understand why the Purkinje cells are undergoing death
because they are responsible for coordinating motor movement.
Pathophysiology of Multiple System Atrophy
MSA has a hallmark of specific oligodendroglial inclusions termed glial
cytoplasmic inclusions (GCis) that contain aggregates of a protein called a-synuclein
(SNCA) (Castellani 1998). Oligodendrocytes are responsible for producing myelin, and
myelin in MSA undergoes extensive degeneration (Castellani 1998; Matsuo et al., 1998).
Interestingly, aggregates containing a-synuclein are observed in other neurodegenerative
diseases such as Parkinson's disease, dementia with Lewy body (DLB) and Lewy Body
Variant of Alzheimer's disease (LBVAD) (Lundvig et al., 2005). These diseases, grouped
together with MSA, have been termed synucleinopathies (Lundvig et al., 2005).
However, these aggregates, seen in the previously mentioned diseases, are not found in
oligodendrocytes as in MSA (Castellani 1998). Instead, aggregations of a-synuclein are
typically found in neurons and are termed neuronal cytoplasmic inclusions (NCis) or
Lewy bodies (Lundvig et al., 2005). Although a-synuclein aggregates are commonly
seen in these diseases, the definite role of a-synuclein in the initiation and progression of
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MSA is still under investigation (Langerveld et al., 2007). Upon investigation of the
distribution of GCis, it was found that GCis tend to aggregate in areas of the brain that
are undergoing degeneration including but not limited to the putamen, spinal cord
intermediate gray matter, middle cerebellar peduncle, and ponto-cerebellar tracts
(Castellani 1998; Walburn 2010).
CXCR4

CXCR4, also called fusin, is a chemokine receptor for the Cys-X-Cys class of
chemokines (Feng et al., 1996; Hesselgesser et al., 1998). Structurally, this cell surface
receptor is a seven transmembrane domain that is linked to G proteins (Bajetto et al.,
1999; Hesselgesser et al., 1998). Upon activation, CXCR4 mediates calcium flux
(Bokoch 1995; Ari & Charo 1996). CXCR4 has been observed as being constitutively
expressed in astrocytes, microglia, neurons, and granule cells (Banisadr et al., 2002;
Ragozzino 2002). Of particular interest for the current study, neuronal expression of
CXCR4 has been found in the following brain areas: cerebral cortex, substantia
innominata, globus pallidus, caudate putamen, substantia nigra,
supraoptic/paraventricular hypothalamic nuclei, and ventromedial thalamic nucleus
(Banisadr et al., 2002). Focusing specifically on neurons, CXCR4 protein expression is
constitutively expressed in Purkinje, dopaminergic, GABAergic, and cholinergic neurons
(Ragozzino 2002; Banisadr et al., 2002; Trecki et al., 2010).
SDF-1

Chemokines are small secreted proteins that have chemoattractant properties,
specifically for immune cells, and they also bind to chemokine receptors to initiate a
signaling cascade (Luster 1998; Luther & Cyster 2001 ). Chemokines are categorized into
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four subfamilies by classification of the spacing of their first two cysteine residues: C,
CC, CXC, and CX3C (Jiang et al., 2012). Stromal cell-derived factor 1 (SDF-1), also
known as chemokine ligand 12 (CXCL 12), is the sole ligand for CXCR4 under normal
conditions (Jiang et al., 2012; Bajetto et al., 1999). It has been found that most
chemokines have the ability to bind to several chemokine receptors and likewise, most
chemokine receptors are able to recognize several chemokines, but SDF-1 is unique in
that it only interacts with CXCR4 (Bacon & Harrison 2000; Cartier et al., 2005).
However, recent studies have shown that there is another receptor for SDF-1 in T
lymphocytes and it is called CXCR7, but currently there is no evidence for the presence
of this receptor in the normal brain (Balabanian et al., 2005). The SDF-1 gene undergoes
alternative mRNA splicing which creates three isoforms: SDF-la,

SDF-1~,

and SDF-1 y,

although most studies tend to focus on SDF-la (Gleichmann et al., 2000; Pillarisetti &
Gupta 2001; Stumm et al., 2002). SDF-1 a protein is constitutively expressed in the
human adult brain in neurons, astrocytes, and microglia (Stumm et al., 2002; Banisadr et
al., 2003). Studies have shown that SDF-la is produced by numerous cell types,
including neuroglia and bone marrow stromal cells (Bleul et al., 1996; Oberlin et al.,
1996). The antibody that was used in this study detects all three forms of SDF-1 (a,

~,

y),

therefore, for the remainder of this paper I will only refer to this protein as SDF-1 (total
SDF-1).

CXCR4/SDF-1 Function as a Pair inthe Mature Brain
Chemokines are notoriously known for their role during inflammatory processes,
such as a host defense response, in which they activate and cause directed migration of
leukocytes (Lazarini et al., 2003). SDF-1 is involved in many important processes in both
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the developing and the mature central nervous system (Lazarini et al., 2003). For
example, SDF-1 is involved in the regulation of cell growth, migration of hematopoietic
stem cells, and it plays an important role in brain development (Lazarini et al., 2003).
Specifically, CXCR4/SDF-1 mediate neuronal migration during formation of the granulecell layer of the cerebellum (Ma et al. 1998; Zou et al. 1998; McGrath et al. 1999).
Similarly with brain development, knockout murine models of the CXCR4 gene result in
fetal death (Bajetto et al., 1999). Blocking the activation of either the CXCR4 or the
SDF-1 gene results in cells in the external granular layer (EGL) to prematurely migrate
into the cerebellum (Ma et al., 1998; Zou et al., 1998). The expression of CXCR4/SDF-1
is absolutely necessary for the development of the dentate gyrus, cerebellum, and
neocortex (Cartier et al., 2005). CXCR4/SDF-1 also plays an important role in central
nervous system processes such as neurogenesis, axonal growth, pain, and
neurotransmission (Tran & Miller 2005; Lieberam et al., 2005; Szabo et al., 2002;
Limatola et al., 2000).
In inflammatory responses, SDF-1 is a strong chemoattractant for cells such as
lymphocytes, monocytes, and CD34+ hematopoietic progenitor cells (Kim & Broxmeyer,
1998). Interestingly, when SDF-1 is expressed at high levels, it leads to selective
repulsion of certain types of T cells (Poznansky et al., 2000). On the other hand, low
levels of SDF-1 result in activation ofleukocytes and release ofleukocytes from
capillaries (Peled et al., 1999). The activation of CXCR4 by SDF-1 leads to many
important processes including the aided migration and proliferation of cerebellar granule
cells, chemoattraction of microglia, and activation of the production and release of
cytokines and glutamate from astrocytes (Lazarini et al., 2003). Additionally, SDF-1
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activation of CXCR4 provokes postsynaptic currents in Purkinje cells, as well as triggers
the migration of cortical neuron progenitors (Lazarini et al., 2003).
CXCR4/SDF-1 Jnvolvement During Inflammation and Disease
The chemokine receptor and ligand pair CXCR4/SDF-1 has gained attention for
its involvement in many diseases. Studies have shown that the signaling system
CXCR4/SDF-1 plays a role in the pathogenesis of tumors (Abi-Younes et al., 2000;
Buckley et al., 2000; Gonzalo et al., 2000; Lukacs et al., 2002). SDF-1 is up-regulated
during the inflammatory processes in diseases such as allergic airway diseases,
rheumatoid arthritis, and artherosclerosis (Abi-Younes et al., 2000; Buckley et al., 2000;
Gonzalo et al., 2000; Lukacs et al., 2002). CXCR4/SDF-1 have been shown to be
overexpressed in inflammatory processes in several brain diseases such as spinocerebellar
ataxia type 3 and experimental allergic encephalitis (EAE) (Lazarini et al. 2003). Local
chemokine release is common in neurodegenerative and neuroinflammatory diseases
such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and human
immunodefiency virus (HIV)-associated dementia (Streit et al., 2001; Vila et al., 2001;
Lee et al., 2002; McGeer & McGeer 2004; Cartier et al., 2005). Specifically, CXCR4 can
act as a receptor for the human immunodefiency virus (HIV-1) glycoprotein gp 120
(Lapham et al., 1996; Berson et al., 1996; Feng et al., 1996). Gp120 has the ability to
signal through CXCR4, therefore this chemokine receptor is of great importance in HIV
(Davis et al., 1997).
CXCR4/SDF-1 Expression in Parkinson's Disease
As previously mentioned, MSA is often misdiagnosed in the beginning stages,
commonly as Parkinson's disease (PD) (Langerveld et al., 2007). Similar to MSA, the
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role of chemokines as inflammatory molecules in Parkinson's disease is without a doubt
very important, but is also not fully understood (Shimoji et al., 2009). Since MSA has
many similarities with Parkinson's disease, it is very interesting that both CXCR4 and
SDF-1 protein expression are up-regulated in PD patients compared to controls (Shimoji
et al., 2009). An Affymetrix DNA microarray study on pons tissue revealed that mRNA
levels of CXCR4 are up-regulated 2.157 fold in MSA compared to controls (Langerveld
et al., 2007). Studies have suggested that CXCR4/SDF-1 play a role in the loss of
dopamine (DA) neurons in PD, yet no studies to date have investigated the cause of
Purkinje cell death in MSA (Shimoji et al., 2009). Interestingly, other studies performed
on rodent brains, or in vitro, have shown that the activation of CXCR4 induces neuronal
apoptosis (Hesselgesser et al., 1998; Meucci et al., 1998; Kaul & Lipton 1999; Zheng et
al., 1999; Bachis & Mocchetti 2004). It has been suggested that the activation of CXCR4
by SDF-1 causes neuronal death in both HIV encephalitis and Parkinson's disease
(Shimoji et al., 2009). Along with PD, CXCR4/SDF-1 signaling has been suggested to
play a role in inflammatory processes and neurodegeneration in a variety of diseases such
as rheumatic arthritis, atherosclerosis, and spinocerebellar ataxia (Burman et al., 2005;
Abi-Younes et al., 2002; Evert et al., 2001).
CXCR4/SDF-1 Expression Affecting Neurons
CXCR4 has been shown to be expressed on neurons and neuroglia (He et al.,
1997; Horuk et al., 1997; Lavi et al., 1997; Ghorpade et al., 1998; Hesselgesser et al.,
1998; Vallat et al., 1998; Zheng et al., 1998; Zou et al., 1998). Interestingly, it has been
shown that if SDF-1 is produced in excess, it has the ability to affect neural function
through CXCR4 signaling (Zheng et al., 1999). Similarly, there is evidence from in vitro
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studies that SDF-1 is neurotoxic (Kaul & Lipton 1999; Bachis & Mocchetti 2004).
CXCR4/SDF-1 have been shown to be neurotoxic to neuronal populations either by a
direct signaling mechanism or an indirect mechanism such as activating microglia to
release neurotoxins (Hesselgesser et al., 1998; Meucci et al., 1998; Kaul & Lipton 1999;
Bezzi et al., 2001). When the neuronal cell line hNT is exposed to either SDF-1 or HIV
gp120, which both play a similar role in activating CXCR4, apoptosis is observed
(Hesselgesser et al., 1998). However, the mechanism that is activated to cause this
neuronal death is currently unknown (Zheng et al., 1999). A study by Zheng and
colleagues investigated the mechanisms for CXCR4-mediated apoptosis and the signaling
pathway for GTP binding protein, since these pathways have the ability to alter neuronal
function (Zheng et al., 1999).
Although the binding of SDF-1 to CXCR4 has the ability to cause cell death in
neurons, cell survival is seen in cell types such as CD4 T cells (Vlahakis et al., 2002). It
is not known why the activation of CXCR4 by SDF-1 does not cause cell death in CD4 T
cells, yet does result in cell death in neurons (Vlahakis et al., 2002). When CXCR4/SDF1 activate Akt, it leads to an anti-apoptotic fate for the cell, such as that seen in the CD4
T cells (Vlahakis et al., 2002). On the other hand, when CXCR4/SDF-1 activate MAPK
(p3 8), the affected cell will become pro-apoptotic, such as that seen in neurons (Vlahakis
et al., 2002). It has also been shown that by inhibiting p38 MAPK, neuronal apoptosis
caused by SDF-1 is reduced (Kaul & Lipton 1999).

CXCR4/SDF-l Activating Apoptosis: Caspase 3
Apoptosis involves a signaling cascade with regulatory genes (Yongue et al.,
2012). One of the most effective and therefore well known apoptotic regulatory genes

12

includes those of the cysteinyl aspartate specific protease (caspase) family (Yonguc et al.,
2012). Caspases are cysteine proteases that play a central role in apoptotic cell death.
Since CXCR4/SDF-1 have been shown in numerous studies to cause neuronal injury, it is
of interest to identify the protein that is activated to ultimately carry out cell death. A
study investigated the Caspase pathway for neuronal apoptosis and found that when
human neurons are treated with SDF-1, Caspase 3 protein was observed (Zheng et al.,
1999). Caspase 3 is a protease that is responsible for neuronal apoptosis (Mogi et al.,
2000; Tatton 2000). Specifically, the protein observed was the 17 kDa form of Caspase 3
(Zheng et al., 1999). Caspase 3 has a precursor form which measures 32 kDa and once it
becomes activated, it has two subunits which are 17 kDa and 11 kDa, all of which can be
identified by Western blot (Zheng et al., 1999). The levels of Caspase 3 that were
measured in the SDF-1 treated neurons increased 2.5-fold compared to controls (Zheng et
al., 1999). Interestingly, activated Caspase 3 is also observed in post-mortem brains of
Parkinson's disease patients (Mogi et al., 2000; Tatton 2000). In the rat striatum, stimuli
that have the ability to activate CXCR4 have been shown to activate Caspase 3, therefore
inducing cell loss (Bachis et al., 2006; Nosheny et al., 2006).
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AIMS OF THE CURRENT STUDY
The aim of this study is to determine if the chemokine and chemokine receptor
SDF-1 and CXCR4 are regulated differently in the Purkinje cells of the Multiple System
Atrophy cerebellum. Since both proteins are constitutively expressed in the mature brain,
my goal is to determine if they are being regulated differently in MSA Purkinje cells
compared to control Purkinje cells. Since MSA is very similar to Parkinson's disease and
studies have shown that both proteins are up-regulated in PD, my hypothesis is that both
proteins will also be up-regulated in the MSA cerebellum. CXCR4/SDF-1 have been
associated with neuronal death in PD and other diseases, therefore I hypothesize that this
pair is also associated with neuronal death in MSA, specifically in the Purkinje cells.
Furthermore, I hypothesize that Caspase 3 protein levels will be increased in Purkinje
cells in MSA, as it has been shown to be increased in post-mortem brains of PD. The
work presented here tested the hypothesis that CXCR4, SDF-1, and Caspase 3 are all upregulated in the Purkinje cells of MSA cerebellum compared to the Purkinje cells of
control cerebellum, suggesting that the CXCR4/SDF-1 signaling system is involved in
Purkinje cell death in MSA.
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MATERIALS AND METHODS
Tissue Collection
Formalin-fixed paraffin-embedded cerebellar tissue sections from MSA and
control patients, measuring 10 µm thick, were obtained from the New York Brain Bank
(NYBB) at Columbia University. Post-mortem neuropathological analysis was performed
at NYBB to deliver a definite diagnosis of MSA. Control tissue was determined as
having no known neuropathology. Cerebellar sections were obtained from six patients
diagnosed with MSA and six control patients with no known neurological diagnosis.
Antibodies
CXCR4 protein was detected using a goat anti-human CXCR4 polyclonal
antibody at a dilution of 1: 150. This antibody detects N terminal amino acids 17-43 of
human CXCR4 purchased from Abeam, Cambridge, MA. The secondary antibody used
in conjunction with CXCR4 was a biotin conjugated donkey anti-goat lgG purchased
from Abeam, Cambridge, MA.
SDF-1 protein was detected using a rabbit anti-human SDF-1 polyclonal antibody
at a dilution of 1:25. This antibody detects total human SDF-1 protein, therefore all three
SDF-1 isoforms were recognized:

a,~,

and y. SDF-1 antibody was purchased from Santa

Cruz Biotechnology, Santa Cruz, CA. The secondary antibody used in conjunction with
SDF-1 was a biotin conjugated goat anti-rabbit IgG purchased from Santa Cruz
Biotechnology, Santa Cruz, CA.
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Caspase 3 protein was detected using a rabbit anti-Caspase 3 polyclonal antibody
at a dilution of 1: 100. This antibody specifically detects the 17 kDa subunit of activated
Caspase 3 purchased from Sigma-Aldrich, St. Louis, MO. The secondary antibody used
in conjunction with Caspase 3 was a biotin conjugated goat anti-rabbit lgG purchased
from Santa Cruz Biotechnology, Santa Cruz, CA.

lmmunohistochemistry
Brain sections fixed on glass slides were deparaffinized and rehydrated with a
series of xylenes and ethanols. Sections were steamed in a 1mM sodium citrate buffer
(pH 6.0) for 40 minutes, allowed to cool at room temperature for 20 minutes, and then
quenched in 3% hydrogen peroxide for 5 minutes in order to block endogenous peroxide
activity. Two 5 minute TBS washes followed the quench. In order to block non-specific
staining, 3% normal goat serum (NGS) for SDF-1 and Caspase 3 antibody, or 3% norn1al
donkey serum (NDS) for CXCR4 antibody was applied for one hour at room temperature.
Brain sections were then incubated with one of the following primary antibodies: antiSDF-1 (1 :25, made in rabbit), anti-CXCR4 (1: 150, made in goat), or anti-Caspase 3
(1 :50, made in rabbit) at 4°C overnight. Following the overnight incubation with the
primary antibody, a series of three 5 minute TBS washes was followed by application of
a biotinylated secondary antibody (goat anti-rabbit for SDF-1 and Caspase 3, donkey
anti-goat for CXCR4) at a dilution of 1: 100. All TBS washes were performed as a series
of three for 5 minutes each, unless stated otherwise. After 3 0 minutes of incubation for
the secondary antibody, sections were washed in a series of TBS washes followed by a
one hour application of Elite Vectastain avi din and biotiny lated horseradish peroxidase
macromolecular complex (ABC complex) (Vector Laboratories, Burlingame, CA).
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Sections were then washed in TBS and antibody staining was visualized with 3'3'
diaminobenzidine (DAB). The brain sections were then dehydrated in a series of
ethanols, cleared with a series of xylenes, and cover slipped using a mounting medium
(Richard-Allan Scientific). Sections labeled as negative controls were processed
simultaneously with the sections that were processed for the primary antibody. These
negative controls underwent the exact same process as those sections that were processed
for the primary antibody, except that the application of the primary antibody was omitted.
The secondary antibody, however, was applied to the negative controls. This was done to
ensure that the staining observed was not non-specific staining due to an unwanted
reaction from a reagent used during the process. The negative controls for SDF-1,
CXCR4, and Caspase 3 all showed no staining; therefore it can confidently be stated that
sections treated with primary antibody were specifically stained.
Image Collection for Analysis
Brain sections from both MSA and control patients were visualized and
photographed using Spot Cooled Color Digital Camera system (Diagnostic Instruments,
Inc, Sterling Heights, Ml) attached to a Nikon Eclipse E600 Microscope. Images were
quantitatively analyzed for protein expression of SDF-1, CXCR4, and Caspase 3. To
ensure that differential background intensities would not affect the analysis, all images
were photographed using the same digital gain settings. Twenty Purkinje cells were
photographed from both MSA and control cerebellar sections. To ensure randomness, ten
images were captured left to right from the top folium and ten images right to left from
the bottom folium. In the event that the section was fixed on the slide at a different
orientation, ten images were captured left to right from the far left folium and ten images
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right to left from the far right folium. To furthermore ensure randomness during image
collection, only every third Purkinje cell was photographed for use in analysis.
Purkinje cells were photographed from the Purkinje cell layer of cerebellar folia.
Figure 1 illustrates one complete foliar section captured at a 4X objective. The arrows
identify one complete folium. The tissue that was fixed on slides for these experiments
contained multiple folia. Images were captured from folia that appeared very similar to
figure 1, but at a 40X objective rather than 4X.

/

Figure 1: Complete Folium of the Cerebellum. A photograph at 4X objective showing a
complete foliar section in the cerebellum. The arrows are within one folium. (Scale bar =
100 µm.)
Image Analysis
Purkinje cells were quantitatively analyzed for protein levels using the ImageJ
program (nih.gov) as described in the ImageJ tutorial pages. Images were calibrated to 10
micrometers using a scale bar for a 40X objective photograph to equal 3.8 pixels per 1
micrometer. The image was then quantitatively analyzed using the color deconvolution
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tool. The color deconvolution tool uses red, green, and blue (ROB) vectors, which are
predetermined values for red and brown color, which differentiate between red (AP) and
brown (DAB) colors. Once the color deconvolution tool is selected, the ImageJ program
automatically generates the following three separate images from the original image: one
with only brown color (DAB), one with only red color (AP), and one with both brown
and red colors (double label). Since all of the proteins analyzed in this study were only
labeled with DAB, only the newly generated image with just brown color was measured.
Therefore, all of the measurements for this study came from the image that was separated
to contain only brown color. The other two generated images with red color (AP) and
brown/red color (double label) were closed. The image was then converted to a black and
white image and the threshold was adjusted. The Purkinje cell was carefully traced using
the free hand drawing tool and was measured for values including area, mean gray value,
integrated density, and circularity. The measurement of integrated density is the value
that was used to measure the amount of antibody stain present in the sections. Integrated
density is the product of area and mean gray value of the selected area. The area is
defined as the area of selection in calibrated units, which are square micrometers, since
the images were spatially calibrated before analyzing. The mean gray value is the sum of
the gray values of all the pixels in the selection divided by the number of pixels.
The CXCR4 that was measured for this thesis was a double labeled IHC (with
CXCR4 being labeled with DAB), but the other antibody was not measured, because the
alkaline phosphatase based staining (red color) did not work. Although the AP did not
work in the double labeled CXCR4 IHC stain, it was decided to analyze the CXCR4
protein because MSA cerebellar sections are not available in excess. Two measures were
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taken in order to ensure that only the CXCR4 was being measured; first, CXCR4 protein
levels were only measured using the brown image obtained from the color deconvolution.
As described earlier, the color deconvolution method was used to separate the brown and
red pixels in the images. The color deconvolution method generates three different
images: one with only brown pixels (DAB), one with only red pixels (AP), and one with
both pixels (double labeled). The CXCR4 antibody measured for this study was labeled
with DAB, which is brown color. Therefore, once the color deconvolution was performed
on this double labeled IHC set, the only image that was analyzed for integrated density
was the one containing only brown pixels. This ensures that only the CXCR4 antibody
labeled with DAB was measured. Secondly, a histogram was created using the program
Photoshop, in which single and doubled labeled Purkinje cells were measured for the
presence of red by the number of pixels with a bright value (Fig. 2). Purkinje cells were
measured for red pixels from the following three separate, previously performed IHC
stains: a single labeled DAB only image, a single labeled AP only image, and the doubled
labeled image from which the CXCR4 was measured. The single labeled images (DAB
only and AP only) were created at an earlier time. The arrows in Figure 2 identify the
measurement of red pixels for the three different IHC stains. Image A is the red pixel
measurement from an AP only image, image Bis the red pixel measurement from a DAB
only image, and image C is the red pixel measurement from the double labeled image
from which CXCR4 was analyzed. The red measurement of AP (Image A) appears to the
far right of the histogram, compared to the red measurements localized to the middle of
the histogram for the measurements of DAB (Image B) and the double labeled image
(Image C). Therefore, images Band Care very similar, showing no measurement ofred
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pixels, as seen in image A. These histograms along with only measuring the brown color
from the color deconvolution method indicates that there was no red color being analyzed
in the double labeled CXCR4 IHC stain. This process was only performed for the
CXCR4 antibody, as the other two antibodies (SDF-1 and Caspase 3) were single labeled
in DAB.

A

B

c

Figure 2: Red Pixel Measurement From CXCR4 Dual Label. "A" shows the
measurement of red pixels from an AP only image. "B" shows the measurement of red
pixels from a DAB only image. "C" is the measurement of red pixels from the double
labeled image that CXCR4 was analyzed from. Arrows identify the measurement of red
pixels. "B" and "C" are very similar, while "A" isn't similar because it is the
measurement of AP alone. The histogram shows that the double labeled (AP & DAB)
image from which CXCR4 was analyzed from is not different from the DAB only image,
therefore, no red was present in the stain that would interfere with the results.
Statistical Tests
Statistics were run using SAS Institute© Statview 5.0. An unpaired T-test was
performed to detect differences in integrated densities between MSA and controls for the
measurements of SDF-1, CXCR4, and Caspase 3. An unpaired T-test was also performed
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to determine the difference between the mean circularity and the mean area of Purkinje
cells in MSA versus control. A p-value of pS 0.05 was considered significant.
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RESULTS
Patient Demographics
Table 1 lists the patients, both MSA and controls, from which cerebellar sections were
used for this study. The patients included in this study have a random, diverse
background as far as age and gender. Age ranges from 44-78 years and both males and
females were involved, which shows that choosing brain sections for this study was a
random process. A diagnosis of MSA is defined as "striato-nigral-olivo-ponto-cerebellar
atrophy with glial cytoplasmic inclusions". A diagnosis of control is defined as "no
diagnostic abnormality recognized". Cold PMI describes the post mortem interval
calculated from the patients reported time of death to the time the patient was brought
into the cold room. Frozen PMI describes the post mortem interval calculated from the
patients reported time of death to the mean time the brain was processed; brain areas used
for histopathology were not frozen, but were fixed in formalin. The term NaN is used for
"not a number", for example, the calculation failed because the time of death or the time
when the patient was brought into the cold room was not reported.
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Patient

Age

Gender

Cold PMI

Frozen PMI

Diagnosis

330

73

Female

3:35

13:15

MSA

4447

65

Female

NaN

NaN

MSA

4485

70

Female

1:05

21:25

MSA

4640

54

Male

1:00

6:10

MSA

4261

61

Male

2:45

33:50

MSA

3873

61

Male

NaN

NaN

MSA

338

67

Male

NaN

NaN

MSA

3569

NaN

No Data

NaN

NaN

MSA

29

68

Male

NaN

NaN

MSA

4523

62

Female

4:33

22:38

Control

99

44

Male

NaN

49:15

Control

4233

74

Male

NaN

NaN

Control

4259

49

Male

NaN

NaN

Control

638

78

Male

NaN

NaN

Control

4534

60

Male

NaN

7:07

Control

Number

Table 1: Patient Demographics from New York Brain Bank at Columbia University.
Demographics of the patients from the New York Brain Bank at Columbia University
used for this study, both MSA and control.
Protein Expression of the Chemokine SDF-1

In order to test the hypothesis that SDF-1 protein levels are up-regulated in MSA
Purkinje cells compared to control Purkinje cells, immunohistochemistry (IHC) was
performed on cerebellar sections obtained from the New York Brain Bank, using a goat
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anti-human SDF-1 antibody. Brain sections of both MSA and control underwent the IHC
method described in detail in the methods section, including a negative control. The
Purkinje cells in the images were carefully outlined and statistically analyzed using color
deconvolution, specifically using only the brown (DAB) image, in the ImageJ program.
Analysis revealed that MSA patients have significantly higher levels of the protein SDF-1
in the Purkinje cells compared to control Purkinje cells (p = 0.0195) (Figure 3).
Integrated density is the measurement unit that quantifies the amount of antibody stain
present in the tissue. Figure 3 is a bar graph representing the SDF-1 mean integrated
densities (area multiplied by mean gray value) for both MSA and control, with the mean
integrated density measurement on the Y axis and patient group on the X axis. SDF-1
integrated density means are as follows; MSA=7.93 x 105 integrated density units,
control= 0.074 x 10 5 integrated density units. These measurements were obtained from
six MSA patients and six control patients.
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Figure 3: Mean Integrated Densities of SDF-1 Immunohistochemistry. Mean integrated
densities of SDF-1 protein in the Purkinje cells ofMSA and control patients; MSA mean
of 7.93 x 10 5 integrated density units compared to control mean of 0.074 x 10 5 integrated
density units. (p = 0.0195; N = 6. Error bars= S.E.)

Images from SDF-1 immunohistochemistry appear in Figure 4, including a
negative control (A), an MSA patient (B), and a control patient (C). The distribution of
SDF-1 appears on the Purkinje cell surface or in the cytoplasm, but not specifically
localized in the nucleus or at one end of the cell. The arrows point to Purkinje cells (PC)
in both MSA and control. The Purkinje cells of the MSA patients are a darker brown
color than the control Purkinje cells showing that SDF-1 protein expression is
significantly higher in the Purkinje cells ofMSA compared to control (Figure 3). Image
A, the negative control, is completely clean of any staining, which demonstrates: that the
staining in images B and C are specific to the protein SDF-1.
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Figure 4: SDF-1 Immunohistochemistry in the Cerebellum. Arrows point to Purkinje
cells (PC). Image A is a photo from the cerebellar section in which the primary antibody
(SDF-1) was not applied (negative control). Image B illustrates SDF-1 expression in an
MSA patient, while image C shows SDF-1 expression in a control patient. (Scale bar=
20 µm.)

Thus, image analysis carried out on Purkinje cells stained via IHC methods shows
expression of the chemokine SDF-1 is significantly up-regulated in MSA cerebellar folia
compared to controls (Figures 3 and 4).
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Protein Expression of the Chemokine Receptor CXCR4

To test the hypothesis that MSA Purkinje cells express the chemokine receptor,
CXCR4, at a significantly higher level than measured in control Purkinje cells,
expression of CXCR4 was analyzed in both MSA and control cerebellar tissue by
performing immunohistochemistry (IHC) on cerebellar sections obtained from the New
York Brain Bank using a donkey anti-human CXCR4 antibody. Brain sections of both
MSA and control underwent the IHC method described in detail in the methods section,
including a negative control. The Purkinje cells in the images were carefully outlined and
statistically analyzed using color deconvolution, specifically using only the brown (DAB)
image, in the ImageJ program. Statistical analysis revealed that the expression of CXCR4
is significantly higher in MSA Purkinje cells compared to control Purkinje cells
(p < 0.0001) (Figure 5). Integrated density is the measurement unit that quantifies the

amount of antibody stain present in the tissue. Figure 5 is a bar graph representing the
CXCR4 mean integrated densities (area multiplied by mean gray value) for both MSA
and control, with the mean integrated density measurement on the Y axis and patient
group on the X axis. CXCR4 mean integrated densities are as follows; MSA=16.34 x 105
integrated density units, control=2.96 x 10 5 integrated density units. These measurements
were obtained from six MSA patients and six control patients.
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Figure 5: Mean Integrated Densities of CXCR4 Immunohistochemistry. Mean integrated
densities of CXCR4 protein in the Purkinje cells of MSA and control patients; MSA
mean of 16.34 x 10 5 integrated density units compared to control mean of 2.96 x
10 5 integrated density units. (p < 0.0001; N = 6. Error bars= S.E.)

Figure 6 shows images from CXCR4 immunohistochemistry, which include a
negative control (A), an MSA patient (B), and a control patient (C). The distribution of
CXCR4 does not appear exclusively in the nucleus or localized to one end of the cell
(CXCR4 is a cell surface receptor). The arrows point to Purkinje cells (PC). Purkinje
cells of MSA patients are a darker brown color than control Purkinje cells, which
demonstrates that CXCR4 protein expression is higher in Purkinje cells of MSA
compared to control. Image A, the negative control, is completely clean of any staining,
which demonstrates that the staining in images B and C are specific to the protein
CXCR4.
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Figure 6: CXCR4 Immunohistochemistry in the Cerebellum. Arrows point to Purkinje
cells (PC). Image A is a photo from the cerebellar section in which the primary antibody
(CXCR4) was not applied (negative control). Image B illustrates CXCR4 expression in
an MSA patient, while image C is CXCR4 expression in a control patient. (Scale bar= 20
µm.)
Therefore, image analysis carried out on Purkinje cells stained via IHC methods
shows expression of the chemokine receptor CXCR4 is significantly up-regulated in
MSA cerebellar folia compared to controls (Figures 5 and 6).
Caspase 3 Expression in Purkinje Cells
In order to test the hypothesis that Caspase 3 protein levels are up-regulated in
MSA Purkinje cells compared to control Purkinje cells, immunohistochemistry (IHC)
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was performed on cerebellar sections obtained from the New York Brain Bank using a
goat anti-human Caspase 3 antibody. Brain sections of both MSA and control underwent
the IHC method described in detail in the methods section, including a negative control.
The Purkinje cells in the photographs were then carefully outlined and statistically
analyzed using color deconvolution, specifically using only the brown (DAB) image, in
the ImageJ program. Statistical analysis revealed that Caspase 3 expression is
significantly higher in MSA Purkinje cells versus control Purkinje cells (p < a.aaa 1)
(Figure 7). Integrated density is the measurement unit that quantifies the amount of
antibody stain present in the tissue. Figure 7 is a bar graph representing the SDF-1 mean
integrated densities (area multiplied by mean gray value) for both MSA and control, with
the mean integrated density measurement on the Y axis and patient group on the X axis.
Caspase 3 integrated density means are as follows; MSA=l 5.38 x 1as integrated density
units, control= 1.53 x 1as integrated density units. These measurements were obtained
from six MSA patients and six control patients.
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p < 0.0001
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Figure 7: Mean Integrated Densities of Caspase 3 Immunohistochemistry. Mean
integrated densities of Caspase 3 protein in the Purkinje cells of MSA and control
patients; MSA mean of 15 .3 8 x 105 integrated density units compared to control mean of
1.53 x 105 integrated density units. (p < 0.0001; N = 6. Error bars= S.E.)

Images from Caspase 3 immunohistochemistry appear in Figure 8,
including a negative control (A), an MSA patient (B), and a control patient (C). The
distribution of Caspase 3 does not appear exclusively in the nucleus or localized to one
end of the cell, but instead in the cytoplasm. The arrows point to Purkinje cells (PC) in
both MSA and control. The Purkinje cells of the MSA patients are a darker brown color
than the control Purkinje cells showing that Caspase 3 protein expression is significantly
higher in the Purkinje cells of MSA compared to control (Figure 8). Image A, the
negative control, is completely clean of any staining, which demonstrates that the staining
in images B and C are specific to the protein Caspase 3.
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Figure 8: Caspase 3 Immunohistochemistry in the Cerebellum. Arrows point to Purkinje
cells (PC). Image A is a photo from the cerebellar section in which the primary antibody
(Caspase 3) was not applied (negative control). Image B illustrates Caspase 3 expression
is dark brown in color in an MSA section, while image C shows Caspase 3 expression is
a lighter color in a control section. (Scale bar= 20 µm.)
Image analysis carried out on Purkinje cells stained via IHC methods shows
expression of the pro-apoptotic protein, Caspase 3, is significantly up-regulated in MSA
cerebellar folia compared to controls (Figures 7 and 8).
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Circularity of Purkinje Cells
To further investigate the hypothesis that MSA Purkinj e cells are undergoing
apoptosis, MSA and controls Purkinje cells were analyzed for circularity. Circularity of
Purkinje cells is of importance because cells that are experiencing cellular stress and/or
apoptosis are irregularly shaped. This was performed by using the free hand drawing tool
to carefully trace each Purkinje cell and having the ImageJ program measure its
circularity. Circularity of the Purkinje cell was evaluated using the value of "l" as being a
perfect circle, therefore, as measurements become further from "l ", they become less
circular. Upon statistical analysis, Purkinje cells from controls are significantly more
circular than those from MSA individuals, suggesting that MSA Purkinje cells are under
stress and experiencing apoptosis (p=0.0033) (Figure 9). Using a value of "1" as being a
perfect circle, circularity measurements are as follows; control mean of 0.688, MSA
mean of 0.594. Figure 9 is a bar graph representing the mean circularity measurements
for both MSA and control, with the mean circularity measurement on the Y axis and
patient group on the X axis. These measurements were obtained from six MSA patients
and six control patients.
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Group
Figure 9: Purkinje Cell Mean Circularity Measurement. Control Purkinje cells are more
circular than those of MSA patients. Using a value of" 1" as a perfect circle, circularity
measurements are as follows; control mean of 0.688, MSA mean of 0.594. (p=0.0033;
N = 6. Error bars= S.E.)

Purkinje cells of MSA patients have an elongated shape when compared to
Purkinje cells of control patients, which have more of a circular shape (Figure 10). Image
A shows a Purkinje cell from an MSA patient while image B shows Purkinje cells of
control tissue. The arrows point to Purkinje cells (PC). The elongated shape seen in
image A is of importance because studies have shown that the morphology of the cellular
membrane changes during the execution phase of apoptosis. MSA patients having
elongated cells further supports the hypothesis that the Purkinje cells in MSA are
undergoing apoptosis.
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Figure 10: Purkinje Cell Circularity. Image A shows an elongated Purkinje cell from
MSA cerebellar tissue, while image B shows a circular control Purkinje cell. The arrows
point to Purkinje cells (PC). (Scale bar= 20 µm.)
Statistical analysis carried out on Purkinje cells shows that control Purkinje cells
are significantly more circular than MSA Purkinje cells, using a value of "1" as a perfect
circle (Figures 9 and 10).
Area ofPurkinje Cells
To ensure that the result showing MSA Purkinje cells to have significantly higher
protein expression (SDF-1, CXCR4, Caspase 3) was not affected by MSA cells possibly
having a larger cellular area, Purkinje cells of MSA patients and control patients were
measured for area. This was performed by using the free hand drawing tool to carefully
trace each Purkinje cell and selecting area measurement in the ImageJ program.
Statistical analysis showed that control Purkinje cells have significantly larger area than
MSA Purkinje cells (p=0.0116) (Figure 11). As previously mentioned, integrated density
is the product of the area and the mean gray value. Therefore, MSA Purkinje cells having
a smaller area means that they have an extremely high mean gray value. Figure 11 is a
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bar graph representing the mean area of Purkinje cells for both control and MSA, with the
following area measurements; control mean of9,547 µm 2 , MSA mean of7,250 µm2 • The
measurement of mean area is labeled on the Y axis and patient group is labeled on the X
axis. These measurements were obtained from six MSA patients and six control patients.
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Figure 11: Purkinje Cell Mean Area Measurement. Control Purkinje cells have a larger
cellular area than those ofMSA patients; control mean of 9,547 µm2 , MSA mean of
7,250 µm2 • (p=0.0116; N = 6. Error bars= S.E.)
Thus, statistical analysis carried out on Purkinje cells shows that control Purkinje
cells have a significantly larger area than MSA Purkinje cells, meaning that MSA
Purkinje cells have an extremely high mean gray value (Figure 11 ).
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DISCUSSION
Chemokines are Implicated in Neurodegeneration
Chemokines and chemokine receptors are involved in the pathogenesis of
numerous neurological disorders, including Alzheimer's disease, multiple sclerosis,
cerebral ischemia, and HIV associated dementia (Cartier et al., 2005). Interestingly, the
pathology of these conditions is associated with the over-expression of certain chemokine
receptors in particular brain areas (Cartier et al., 2005). Chemokines have been
implicated as important inflammatory molecules in Parkinson's disease, however, their
role is not fully understood (Shimoji et al., 2009). This is similar to MSA, since the role
of chemokines in this disease is under investigation.
Furthermore, there is emerging evidence that chemokine receptors are involved in
neuronal death and therefore, neurodegenerative diseases (Cartier et al., 2005). Several
neurological disorders present with neuronal injury and death (Cartier et al., 2005). For
example, damaged neurons are observed in Alzheimer's disease and neuronal loss is seen
in multiple sclerosis (Akiyama et al., 2000; Kutzelnigg et al., 2007). The neurological
disorder HIV -1 encephalitis (HIVE) also presents with loss of neuronal subpopulations
(Glass et al., 1993; Koenig et al., 1986).
Neuronal Degeneration
Neuronal loss is of importance because it results in behavioral pathology such as
ataxia, which is loss of motor coordination (Sama & Hawkes 2003 ). In another example,
slowing of motor movements, or Parkinsonian motor abnormalities, is observed in
Parkinson's disease, MSA, and HIV-1 encephalitis (Glass et al., 1993; Koenig et al.,
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1986; Berger & Arendt, 2000; Koutsilieri et al., 2002; McArthur 2004; Nath & Berger,
2004). MSA involves extensive loss of a particular population of neurons called Purkinje
cells, which are located in the cerebellum, and are responsible for coordinating muscle
movements (Spokes et al., 1979; Kume et al., 1991; Wenning et al., 1996; Herndon
1963). Degeneration of Purkinje cells phenotypically presents as ataxia and tremor, yet
the cause of Purkinje cell death in MSA in unknown (Sarna & Hawkes 2003; Wenning et
al., 2004; Ozawa et al., 2004; Stefanova et al., 2005; Wenning et al., 1997).

CXCR4/SDF-1 in Parkinson's Disease
The present study drew upon available information regarding neuronal death in
Parkinson's disease, a neurodegenerative disease that is characterized by tremors, similar
to MSA. Studies performed on post-mortem Parkinson's disease (PD) brains and mouse
models of PD (MPTP-treated mice) investigated the role of the signaling pair, CXCR4
and SDF-1, in neuronal death. Parkinson's disease patients express both CXCR4 and
SDF-1 at higher levels compared to controls (Shimoji et al., 2009). Activation of CXCR4
by SDF-1 has been suggested to cause neuronal death, specifically dopamine neurons, in
Parkinson's disease (Shimoji et al., 2009). CXCR4/SDF-1 signaling has also been shown
to cause neuronal death in HIV encephalitis (Shimoji et al., 2009). Furthermore, studies
have shown that post-mortem PD brains exhibit activated Caspase 3, which is the
protease expressed during the execution phase of neuronal apoptosis (Mogi et al., 2000;
Tatton 2000). This information, together with an Affymetrix DNA microarray on MSA
pons tissue revealing up-regulation of CXCR4 mRNA, directed the current study to
investigate protein levels of CXCR4, SDF-1, and Caspase 3 in MSA Purkinje cells
compared to control Purkinje cells.
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Purkinje Cells from MSA Cerebella Characterized in the Current Study
Multiple System Atrophy is a neurodegenerative disease with little information
available regarding specific proteins involved in regulating cell death in diseased,
dysfunctional brain tissues. However, this thesis shows for the first time that the levels of
three proteins involved in neuronal apoptosis, i.e., SDF-1, CXCR4, and Caspase 3, are all
significantly up-regulated in MSA Purkinje cells compared to control Purkinje cells.
Furthermore, the fact that MSA Purkinje cells are significantly less circular than control
Purkinje cells, supports the idea that MSA Purkinje cells are undergoing cellular stress
and/or apoptosis. In addition, the fact that control Purkinje cells have a significantly
larger area than MSA Purkinje cells, confirms image analysis results indicating that MSA
Purkinje cells have significantly more antibody stain for the three proteins measured in
the study.
CXCR4 and SDF-1 Expression in Multiple System Atrophy
Although it is unclear why Purkinje cells in MSA degenerate, this study suggests
for the first time that CXCR4/SDF-1 may play a role in neuronal death in MSA, as has
been shown in Parkinson's disease (PD) (Shimoji et al., 2009). SDF-1 is a chemokine
that has chemoattractant properties, specifically for immune cells, and it also binds to the
chemokine receptor, CXCR4, to initiate a signaling cascade (Luster 1998; Luther &
Cyster 2001 ). The research presented in this thesis is the first to quantitatively
demonstrate that these two proteins are significantly up-regulated in the Purkinje cells of
MSA patients compared to control Purkinje cells (SDF-1, p=0.0195; CXCR4, p<0.0001).

It is interesting that both proteins are up-regulated in MSA, and PD, since MSA has so

40

many similarities to PD, such as behavioral symptoms, neuronal loss and the presence of
aggregates containing misfolded alpha-synuclein.
Caspase 3 Expression in Multiple System Atrophy
Caspase 3 protein is involved in execution of apoptosis (Mogi et al., 2000; Tatton
2000). During induction of apoptosis, Caspase 3 becomes cleaved into two activated
subunits, 11 kDa and 17kDa (Zheng et al., 1999). In a study performed by Zheng and
colleagues, neurons treated with SDF-1 increased levels of Caspase 3 when compared to
controls (Zheng et al., 1999). Thus, it was important to investigate Caspase 3 levels in
MSA Purkinje cells, since our earlier experiments showed that MSA Purkinje cells
express SDF-1 at higher levels than controls (Zheng et al., 1999).
The activated 17 kDa subunit of Caspase 3 was investigated in this study to
determine if Purkinje cells are experiencing more apoptosis driven by activation of the
Caspase pathway, possibly related to CXCR4/SDF-1 signaling. Caspase 3 levels are also
of importance because activated Caspase 3 levels are increased in post-mortem PD brains
compared to controls (Mogi et al., 2000; Tatton 2000). Similarly, work carried out in the
current thesis showed that Caspase 3 levels are significantly higher in MSA Purkinje cells
compared to control Purkinje cells (p<0.0001).
Purkinje Cell Circularity
This thesis also investigated the circularity of Purkinje cells, and found MSA cells
to be less circular than control Purkinje cells (p=0.0033). This is of importance because
studies have shown that cells change their cellular membrane morphology during the
execution phase of apoptosis, producing cell bodies that lose their robust circularity
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(Coleman et al., 2001 ). Therefore, both Caspase 3 expression increases and changes in
cell morphology indicate that MSA Purkinje cells are undergoing apoptosis. These results
are compatible with the suggestion that CXCR4/SDF-1 are playing a central role in
Purkinje cell death in MSA.
Purkinje Cell Area
The area of MSA Purkinje cells was measured and compared to control Purkinje
cells, and it was found that MSA Purkinje cells have a significantly smaller area than
control Purkinje cells (p=O.O 116). As the previous results stated, MSA Purkinje cells had
greater integrated density for the three proteins (SDF-1, CXCR4, Caspase 3) compared to
control Purkinje cells. Since integrated density is the product of cellular area and mean
gray value of stain, MSA Purkinje cells having less area than controls means that the
amount of protein present was relatively higher compared to controls than integrated
density measurements indicate.
CXCR4/SDF-1 as Neurotoxic Molecules
There have been studies that investigate whether CXCR4/SDF-1 are neurotoxic to
neuronal populations by either a direct mechanism, or an indirect mechanism, such as
induction of the release of neurotoxins from microglia (Hesselgesser et al., 1998; Meucci
et al., 1998; Kaul & Lipton, 1999; Bezzi et al., 2001 ). Activated microglia secrete
neurotoxins, such as pro-inflammatory cytokines that can cause neuronal injury (Shimoji
et al., 2009). However, signaling by CXCR4 has the ability to cause neuronal death even
when pro-inflammatory cytokines are not present, as illustrated by in vivo models of PD
(Shimoji et al., 2009). This suggests that CXCR4/SDF1 signaling has the potential to
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cause neuronal death by a direct signaling cascade mechanism, such as the pro-apoptotic
Caspase 3 pathway. The fact that CXCR4/SDF-1 have the ability to cause apoptosis
without other molecules present strengthens the idea that CXCR4/SDF-1 signaling are
involved in apoptosis in MSA. Along with SDF-1 having the ability to induce Caspase 3,
there may also be other pro-apoptotic signals involved such as MAPK (p3 8), as suggested
by other studies (Vlahakis et al. 2002).
Involvement in Multiple Sclerosis
SDF-1 has been shown to play a role in inflammation. Calderon and colleagues
have shown that SDF-1 is an important factor in the pathogenesis in multiple sclerosis
(MS) (Calderon et al., 2006). MS is an autoimmune, inflammatory, demyelinating disease
in which there is extensive loss of myelin axons in lesions found within the central
nervous system (Calderon et al., 2006). This is of interest because MSA and MS share
many similarities, such as oligodendrocyte damage, demyelination, and neuronal injury
(Calderon et al., 2006). Specifically, the pathogenic nature of MS involves leukocyte
chemotaxis into the central nervous system and the production of inflammatory
molecules, thereby causing neuropathology (Calderon et al., 2006). Inflammation,
demyelination, and neurodegeneration are intimately linked together (Geurts & Barkhof,
2008). SDF-1 is a chemoattractant for not only both resting and activated T cells, but also
monocytes (Calderon et al., 2006). SDF-1 has been investigated in MS as being
responsible for chemotaxis of T cells, as well as leukocytes during inflammation
(Calderon et al., 2006). Studies have shown that SDF-1 is expressed at a higher level in
active lesions, which are lesions that have the presence of inflammatory cell infiltration
(Calderon et al., 2006). SDF-1 expression is also higher in active MS lesions when
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compared to normal brain (Calderon et al., 2006). This suggests that SDF-1 expression
may be an important component in the initial events of the development of MS lesions by
recruiting inflammatory cells such as T cells and monocytes (Calderon et al., 2006). The
recruitment of these cells further amplifies the inflammatory response which ultimately
leads to damage (Calderon et al., 2006). Although MSA is mainly characterized as a
neurodegenerative disease, it also has components of chronic inflammation, such as
cellular infiltration, for example, CD8 leukocytes, which is similar to MS (Van Wagner et
al., 2012). Both diseases present with oligodendrocyte and neuronal injury, as well as
demyelination, which are consequences of inflammation. Therefore, it is very likely that
the up-regulation of SDF-1 in MSA is playing a role in leukocyte infiltration which is
causing damage in MSA, similar to what it has been shown to do in active MS lesions.
SDF-1 plays a role in many important processes so it is not surprising that it is possibly
amplifying inflammation in MSA as well as playing a role in Purkinje cell death.
Post-mortem analysis on multiple sclerosis brains revealed that there is significant
loss of Purkinje cells in MS patients (Kutzelnigg et al., 2007). In a mouse experimental
model of MS called experimental autoimmune encephalomyelitis (EAE), it was
discovered that Purkinje cell loss clearly correlates with gray matter atrophy in the
cerebellum (MacKenzie-Graham et al., 2009). This study found that Purkinje cell density
was not compromised during early stages of EAE, but only during later stages of the
disease (MacKenzie-Graham et al., 2009). This finding suggests for MSA a possibility
that CXCR4/SDF-1 play a role in inflammation to begin with, and secondarily as being
involved in neuronal death. These previously mentioned studies present another
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similarity that MSA shares with MS, which suggests that studies performed on MS could
also possibly be considered as relevant information for MSA.
CXCR4 in Human Immunodeficiency Virus
Another disease in which CXCR4 plays a role in is the human immunodeficiency
virus (HIV-1) where it acts as a receptor for the glycoprotein gp120 (Lapham et al., 1996;
Berson et al., 1996; Feng et al., 1996). Interestingly, it is believed that CXCR4/SDF1signaling plays a role in the neuronal injury that is associated with HIV-1 infection
(Lavi et al., 1998; Miller et al., 1999; Gabuzda et al., 2000; Martin-Garcia et al., 2002;
Rostasy et al., 2003). Specifically, studies have indicated that CXCR4 signaling plays an
important role in HIV-induced dementia and neuronal apoptosis (Biard-Piechaczyk et al.,
2000; Bezzi et al., 2001; Corasaniti et al., 2001). This further supports that CXCR4/SDF1 may be causing neuronal death in MSA as it does in HIV.
Future Analyses
Immunohistochemistry performed in this study suggests there is a quantitative
difference between protein expression of SDF-1, CXCR4, and Caspase 3 in the granule
cells between MSA and controls, as well as the Purkinje cells. However, statistical
analysis of the granule cells is beyond the scope of this thesis. Future analyses will be
performed to investigate this topic in detail.
Conclusion
Although the cause of the pathogenesis of MSA is still a mystery, this study
suggests a cause for the death of the Purkinje cells in the MSA cerebellum. This work
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shows for the first time that the protein levels of CXCR4, SDF-1, and Caspase 3 are all
up-regulated in the Purkinje cells of MSA patients compared to controls. In vivo studies
on animals would be necessary in order to investigate if CXCR4/SDF-1 signaling is
activating Caspase 3, thereby causing neuronal death, similar to what has been performed
related to Parkinson's disease. If CXCR4/SDF-1 are indeed causing Purkinje cell death in
MSA as suggested by this study, new therapeutics might be developed to intervene in this
pathway. This work not only benefits MSA, but also has the therapeutic potential for
drugs that might be used to treat other diseases that involve CXCR4/SDF-1 such as
Parkinson's disease, multiple sclerosis, and HIV.
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